$251.26
-4.34[-1.70%]
Last update: 9:30AM Get Real Time Here
Roche Holding
(OTCQX:RHHBF)Latest News for Roche Holding Stock (OTC:RHHBF)
Roche Holding Stock (OTC: RHHBF)
Categories: All
Wednesday, April 10, 2024
Tuesday, April 09, 2024
Tuesday, March 12, 2024
Monday, February 26, 2024
- Codexis Enters Exclusive Licensing Agreement With Roche For Double-Stranded DNA LigaseBenzinga Newsdesk - Feb 26, 2024, 4:10PM
- Reported Earlier, Roche's Genentech Announced Data From Stage 1 Of The National Institutes Of Health (NIH)-Sponsored Pivotal Phase III Outmatch Study Evaluating The Efficacy And Safety Ofxolair®Benzinga Newsdesk - Feb 26, 2024, 3:11AM
Tuesday, February 13, 2024
Thursday, February 01, 2024
Friday, January 26, 2024
Tuesday, January 16, 2024
Tuesday, January 02, 2024
Tuesday, December 19, 2023
Monday, December 11, 2023
- Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical TrialVandana Singh - Dec 11, 2023, 11:17AM
- Roche's Genentech Presented New Data From Its CD20xCD3 T-Cell Engaging Bispecific Antibody Program At The 65th American Society Of Hematology (ASH) Annual MeetingBenzinga Newsdesk - Dec 11, 2023, 2:08AM
Tuesday, December 05, 2023
- Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With MutationVandana Singh - Dec 5, 2023, 8:30AM
- Roche's Genentech Announces Phase III Results For Inavolisib Combination In People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With A PIK3CA MutationBenzinga Newsdesk - Dec 5, 2023, 1:07AM
Monday, December 04, 2023
Tuesday, October 31, 2023
Friday, October 27, 2023
Monday, October 23, 2023
Thursday, October 19, 2023
Wednesday, October 18, 2023
Tuesday, October 17, 2023
Thursday, October 12, 2023
Wednesday, October 11, 2023
- Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite ReadyVandana Singh - Oct 11, 2023, 2:27PM
- Roche's Genentech Announces Results From The Phase IV CHIMES Trial Evaluating Ocrevus® In Black And Hispanic / Latinx People With Relapsing Multiple SclerosisBenzinga Newsdesk - Oct 11, 2023, 3:10AM
- Roche's Genentech Announces Late-Breaking Data From The Phase III OCARINA II StudyBenzinga Newsdesk - Oct 11, 2023, 3:08AM
Wednesday, October 04, 2023
- Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding SharesDaniel Harrison - Oct 4, 2023, 9:49AM
- Roche Group's Genentech Presented Results From The Primary Analysis Of The Ongoing RAINBOWFISH Study, Assessing The Efficacy And Safety Of Evrysdi® In Babies, At The 28th World Muscle Society CongressBenzinga Newsdesk - Oct 4, 2023, 1:59AM
Wednesday, September 27, 2023
Thursday, September 21, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
Friday, September 01, 2023
Wednesday, August 30, 2023
Tuesday, August 29, 2023
Wednesday, August 23, 2023
- Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data UpdateVandana Singh - Aug 23, 2023, 3:05PM
- Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy StudyVandana Singh - Aug 23, 2023, 7:48AM
- Roche's Genentech Provides Update On Phase III SKYSCRAPER-01 Study In PD-L1-High Metastatic Non-Small Cell Lung CancerBenzinga Newsdesk - Aug 23, 2023, 1:57AM
Monday, August 21, 2023
Friday, July 28, 2023
Thursday, July 27, 2023
Wednesday, July 26, 2023
Monday, July 24, 2023
- Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension TherapyVandana Singh - Jul 24, 2023, 8:50AM
- Alnylam Partners With Roche To Develop And Commercialize Zilebesiran, Alnylam's Investigational RNAi Therapeutic For The Treatment Of HypertensionBenzinga Newsdesk - Jul 24, 2023, 1:53AM